Surrogate Outcomes from the Users' Guides to the Medical Literature
JAMAevidence Users' Guides to the Medical LiteratureShow Notes
Anne M. Holbrook, MD and Gordon Guyatt, MD, discuss Surrogate Outcomes from the JAMA Users' Guides to the Medical Literature Related Content: When Can Intermediate Outcomes Be Used as Surrogate Outcomes? FDA Acceptance of Surrogate End Points for Cancer Drug Approval: 1992-2019 What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials?
More from JAMAevidence Users' Guides to the Medical Literature
Toshi A Furukawa, MD, PhD, Kyoto University, Graduate School of Medicine, School of Public Health, discusses Understanding Bias and Random Error in Medical Research with Gordon H. Guyatt, MD, MSc, McMaster University.
Thomas Agoritsas, MD, PhD, Geneva University Hospitals, Switzerland discusses Users' Guides to the Medical Literature about patient management recommendations with author Gordon H. Guyatt, MD, MSc, McMaster University.
Mark C. Wilson, MD, MPH, University of Iowa, Carver College of Medicine discusses Evidence-Based Practitioners and Evidence-Based Care with Gordon H. Guyatt, MD, MSc, McMaster University.
Mark C. Wilson MD, MPH, University of Iowa, discusses Teachers' Guides to the Users' Guides with Gordon H. Guyatt, MD, MSc, McMaster University.
Gordon H. Guyatt, MD, MSc, discusses Assessing the Strength of Recommendations: The GRADE Approach with Per Olav Vandvik, MD, PhD.